-
1دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
3
المؤلفون: Morra F., Merolla F., Criscuolo D., Insabato L., Giannella R., Ilardi G., Cerrato A., Visconti R., Staibano S., Celetti A.
المصدر: Journal of experimental & clinical cancer research (Online) 38 (2019). doi:10.1186/s13046-019-1087-1
info:cnr-pdr/source/autori:Morra F.; Merolla F.; Criscuolo D.; Insabato L.; Giannella R.; Ilardi G.; Cerrato A.; Visconti R.; Staibano S.; Celetti A./titolo:CCDC6 and USP7 expression levels suggest novel treatment options in high-grade urothelial bladder cancer 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis 06 Biological Sciences 0601 Biochemistry and Cell Biology/doi:10.1186%2Fs13046-019-1087-1/rivista:Journal of experimental & clinical cancer research (Online)/anno:2019/pagina_da:/pagina_a:/intervallo_pagine:/volume:38مصطلحات موضوعية: Biomarkers, DNA damage, DNA repair, PARP-inhibitor, P5091, RRx-001, Viral mimicry, Epigenetic, Immunotherapy, Precision medicine
URL الوصول: https://explore.openaire.eu/search/publication?articleId=cnr_________::8050d13d85a6254c2d589a9e29c1c46a
-
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5
المؤلفون: Cerrato A., Merolla F., Morra F., Celetti A.
المصدر: International journal of cancer (Online) (2017). doi:10.1002/ijc.31106
info:cnr-pdr/source/autori:Cerrato A.; Merolla F.; Morra F.; Celetti A./titolo:CCDC6: The identity of a protein known to be partner in fusion/doi:10.1002%2Fijc.31106/rivista:International journal of cancer (Online)/anno:2017/pagina_da:/pagina_a:/intervallo_pagine:/volumeمصطلحات موضوعية: PARPi, HR, BRCAlike, Synthetic-lethal, Targeted-therapy, DDR, TKi
URL الوصول: https://explore.openaire.eu/search/publication?articleId=cnr_________::93ba241d6144ade966f1bf7a80e61fa4
http://www.scopus.com/inward/record.url?eid=2-s2.0-85032187530&partnerID=q2rCbXpz -
6دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
7مؤتمر
المؤلفون: Morra, F
المساهمون: Lewin and Assocs. Inc.
المصدر: SPE Annual Technical Conference and Exhibition.
-
8مؤتمر
المؤلفون: Morra, F
المساهمون: Lewin and Assocs. Inc.
المصدر: SPE Annual Technical Conference and Exhibition.
-
9مؤتمر
المؤلفون: Morra, F
المساهمون: Lewin and Assocs. Inc.
المصدر: SPE Annual Technical Conference and Exhibition.
-
10
المؤلفون: Morra, F, Luise, C, Visconti, R, Staibano, S, Merolla, Francesco, Ilardi, G, Guggino, G, Paladino, S, Sarnataro, D, Franco, R, Monaco, R, Zitomarino, F, Pacelli, R, Monaco, G, Rocco, G, Cerrato, A, Linardopoulos, S, Muller, Mt, Celetti, A.
المساهمون: Morra, F, Luise, C, Visconti, R, Staibano, Stefania, Merolla, F, Ilardi, Gennaro, Guggino, G, Paladino, Simona, Sarnataro, Daniela, Franco, R, Monaco, R, Zitomarino, F, Pacelli, Roberto, Monaco, G, Rocco, G, Cerrato, A, Linardopoulos, S, Muller, Mt, Celetti, A.
المصدر: International journal of cancer
(2014).
info:cnr-pdr/source/autori:Morra F1, Luise C, Visconti R, Staibano S, Merolla F, Ilardi G, Guggino G, Paladino S, Sarnataro D, Franco R, Monaco R, Zitomarino F, Pacelli R, Monaco G, Rocco G, Cerrato A, Linardopoulos S, Muller MT, Celetti A./titolo:New therapeutic perspectives in CCDC6 deficient lung cancer cells./doi:/rivista:International journal of cancer (Print)/anno:2014/pagina_da:/pagina_a:/intervallo_pagine:/volume
136 (2015): 2146–2157. doi:10.1002/ijc.29263
info:cnr-pdr/source/autori:Morra F.; Luise C.; Visconti R.; Staibano S.; Merolla F.; Ilardi G.; Guggino G.; Paladino S.; Sarnataro D.; Franco R.; Monaco R.; Zitomarino F.; Pacelli R.; Monaco G.; Rocco G.; Cerrato A.; Linardopoulos S.; Muller M.T.; Celetti A./titolo:New therapeutic perspectives in CCDC6 deficient lung cancer cells/doi:10.1002%2Fijc.29263/rivista:International journal of cancer (Print)/anno:2015/pagina_da:2146/pagina_a:2157/intervallo_pagine:2146–2157/volume:136مصطلحات موضوعية: Male, Resistance to platinum salts and PARP-1 inhibitor sensitivity, DNA Repair, POLY(ADP-RIBOSE) POLYMERASE, NSCLC, Disease-Free Survival, Candidate biomarker, Antineoplastic Agent, Author Keywords:NSCLC, Carcinoma, Non-Small-Cell Lung, Cell Line, Tumor, Cytoskeletal Protein, resistance to platinum salts and PARP-1 inhibitor sensitivity KeyWords Plus:HOMOLOGY-DIRECTED REPAIR, CCDC6, DNA damage and homologous-directed repair, candidate biomarker, BRCA MUTATION CARRIERS, DNA-REPAIR, SENSITIVITY, RET, ADENOCARCINOMA, CHEMOTHERAPY, RESISTANCE, INHIBITORS, Piperazine, Aged, Phthalazine, Aged, 80 and over, Apoptosi, Lymphatic Metastasi, Middle Aged, Lung Neoplasm, Female, Rad51 Recombinase, Cisplatin, DNA damage and homologousdirected repair, DNA Damage, Human
URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5ee4db45c33a113d191215eb7ecc1b54
http://www.cnr.it/prodotto/i/286412
